UBE2N and acute myeloid leukemia: Among the E2s, UBE2N emerged as a top hit, as it exhibited a high AML dependency score (score = –0.813) (Figure 1, B and C) and its elevated expression in AML correlated with worse overall survival (P = 0.019) (Supplemental Figure 1A).